Sunday, November 1, 2009 Promoter Design, Characterization & - - PowerPoint PPT Presentation

sunday november 1 2009 promoter design characterization
SMART_READER_LITE
LIVE PREVIEW

Sunday, November 1, 2009 Promoter Design, Characterization & - - PowerPoint PPT Presentation

Sunday, November 1, 2009 Promoter Design, Characterization & Consequences Virginia Commonwealth University Richmond, VA Craig Alberg Adam Bower Kevin Bussing Richard Crenwelge Maria McClintock Afton Trent CONFIDENTIAL Sunday, November


slide-1
SLIDE 1

Sunday, November 1, 2009

slide-2
SLIDE 2

CONFIDENTIAL

Promoter Design, Characterization & Consequences

Virginia Commonwealth University Richmond, VA

Craig Alberg Adam Bower Kevin Bussing Richard Crenwelge Maria McClintock Afton Trent

Sunday, November 1, 2009

slide-3
SLIDE 3

CONFIDENTIAL

Overview

  • Kevin

– Introduction – Project Design

  • Maria

–Characterization –Conclusion

Sunday, November 1, 2009

slide-4
SLIDE 4

CONFIDENTIAL

Questions

  • Can we design novel UP-element sequences to enhance or

attenuate gene expression?

  • What is the most streamline and effective method of characterizing

these and other BioBrick parts?

  • Can we further characterize existing Registry parts in a way that is

useful to the community?

Sunday, November 1, 2009

slide-5
SLIDE 5

CONFIDENTIAL

Libraries of BioBrick Parts

Promoters Backbones UP-elements Sunday, November 1, 2009

slide-6
SLIDE 6

CONFIDENTIAL RNA Polymerase

β β' Ϭ α α-CTD

  • 35
  • 10

UP-element

Transcribed into mRNA

Initiation of Transcription by UP-element and Promoter

Sunday, November 1, 2009

slide-7
SLIDE 7

CONFIDENTIAL Naturally occurring UP-element sequences with relative activity listed.

(adapted from Estrem ST, Gaal T, Ross W, Gourse RL, Identification of an UP element consensus sequence for bacterial promoters, PNAS, (1998), 95, 9761-9766 PubMed)

Relative activity in this application is a comparison to the CORE sequence. This is a non-UP- Element sequence

Sunday, November 1, 2009

slide-8
SLIDE 8

CONFIDENTIAL

Hypothesis

  • The variation of strength of the UP-element is due to different

combinations of nucleotides in the non conserved regions of the UP-element.

  • There is some correlation between UP-element strength and the

frequency of bases in the sequence.

  • The strength of the UP-element can be tuned by mutating individual

nucleotides of the consensus UP-element sequence using the statistical frequency of occurrence.

Sunday, November 1, 2009

slide-9
SLIDE 9

CONFIDENTIAL The frequency of

  • ccurrence of each

nucleotide at each position was analyzed for a correlation to UP- element strength.

Sunday, November 1, 2009

slide-10
SLIDE 10

CONFIDENTIAL

Variable Regions of the UP-element with Tabulated Base Pair Frequency

Sunday, November 1, 2009

slide-11
SLIDE 11

CONFIDENTIAL

The UP-elements Inner Workings

The distal and proximal sequences fall within the consensus region of the UP-element.

Distal Proximal

The alpha carboxy terminal domains of the polymerase bind to these sub sequences.

Sunday, November 1, 2009

slide-12
SLIDE 12

CONFIDENTIAL

Nucleotide Mutations to Test Hypothesis

Sunday, November 1, 2009

slide-13
SLIDE 13

CONFIDENTIAL

Current Measurement Techniques

Current measurement techniques look only at protein expression, putting the system in a black box.

Sunday, November 1, 2009

slide-14
SLIDE 14

CONFIDENTIAL

Removing the Black Box

To fully understand the system we must be able to analyze transcript levels as well as protein levels.

Sunday, November 1, 2009

slide-15
SLIDE 15

CONFIDENTIAL

  • Methods & Measurements
  • Results
  • Conclusions
  • Future Ideas
  • Acknowledgements

Sunday, November 1, 2009

slide-16
SLIDE 16

CONFIDENTIAL

Measurements

  • Fluorescence by Flow Cytometry
  • Measures fluorescence in each individual cell
  • Gives cell count
  • mRNA Levels by rt-PCR
  • Gives the amount of mRNA found in sample
  • Eliminates the black box

Sunday, November 1, 2009

slide-17
SLIDE 17

CONFIDENTIAL

Minimal Measurement Standard

  • Take away the mystery between DNA level and Protein level
  • To better characterize transcriptional BioBrick pieces
  • Better characterization will aid the development of standard parts
  • Make synthetic biology an engineerable process

Sunday, November 1, 2009

slide-18
SLIDE 18

CONFIDENTIAL

Methods: Anderson Promoters

  • High-copy number plasmid

(pSB1C3)

  • Low-copy number plasmid (pSB3K3)
  • Additional Characterization and

reproduction of previous characterization

Sunday, November 1, 2009

slide-19
SLIDE 19

CONFIDENTIAL Two Scenarios for Testing:

  • Constant promoters with variable strength UP-elements
  • Constant UP-elements with variable strength promoters

Methods: UP-elements

Sunday, November 1, 2009

slide-20
SLIDE 20

CONFIDENTIAL

Anderson Promoter Characterization

Sunday, November 1, 2009

slide-21
SLIDE 21

CONFIDENTIAL

Anderson Promoter Characterization

Sunday, November 1, 2009

slide-22
SLIDE 22

CONFIDENTIAL

Case 1 - Different UP-elements Same Promoter

Sunday, November 1, 2009

slide-23
SLIDE 23

CONFIDENTIAL

Case 2 - Same UP-element with Promoters of Varying Strength

Sunday, November 1, 2009

slide-24
SLIDE 24

CONFIDENTIAL

Conclusion

  • The UP-element can be too strong in these cases
  • Prevents transcription from continuing
  • Brings the mRNA production within a specific range
  • mRNA levels made it possible for us to come to a more definitive

conclusion

Sunday, November 1, 2009

slide-25
SLIDE 25

CONFIDENTIAL

Contributions:

  • Addition of a New BioBrick category
  • Addition of a New BioBrick
  • Additional Characterization of Anderson Promoters
  • Proposed Minimal Measurement Standard

Sunday, November 1, 2009

slide-26
SLIDE 26

CONFIDENTIAL

Future Work

  • Tighter normalization of rt-PCR Data using RecA
  • Further develop UP-elements as well-characterized BioBrick parts
  • Use previously proposed promoter reference standard (Kelly J.R. et al. 2009)
  • Determine the effect of the scarring region on BioBrick UP-elements
  • Determine if UP-elements alone can initial transcription
  • Look into the delayed expression of the RFP in the E. coli

Sunday, November 1, 2009

slide-27
SLIDE 27

CONFIDENTIAL

Acknowledgements

  • Dr. Stephen Fong
  • Cindy Lovelace
  • Dr. John Ryan
  • Chris Gowen
  • George McArthur IV
  • Howard Hughs Medical Institute Summer Scholars Program
  • VCU Nucleic Acids Research Facility
  • University of Virginia iGEM 2009 Team

Sunday, November 1, 2009